Amneal Pharmaceuticals
AMRX
#3516
Rank
C$5.25 B
Marketcap
C$16.46
Share price
-1.74%
Change (1 day)
38.94%
Change (1 year)

Operating Margin for Amneal Pharmaceuticals (AMRX)

Operating Margin as of March 2026 (TTM): 4.61%

According to Amneal Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 4.61%. At the end of 2025 the company had an Operating Margin of 12.60%.

Operating Margin history for Amneal Pharmaceuticals from 2018 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202512.60%72.89%
20247.29%2.38%
20237.12%-275.44%
2022-4.06%-150.65%
20218.01%44.79%
20205.53%-272.88%
2019-3.20%-10.05%
2018-3.56%-115.17%
201723.45%-11.6%
201626.53%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-24.83%-638.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-8,391.15%-182,120.61%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.